Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Expert Opin Ther Targets. 2014 Mar 1;18(5):555–569. doi: 10.1517/14728222.2014.892926

Table 2.

Summary of potential PRL effector molecules.

PRL effector
molecule
Effect of PRL
Overexpression
Reference
p53 Inhibition (62,63)
Src Activation (54,67,68)
ERK1/2 Activation (54,67,68)
STAT3 Activation (54,67,68)
p130Cas Activation (54,67,68)
Csk Inhibition (54,67)
MMPs Activation (68)
FAK Activation (PRL1) (68)
Rho A and C Activation (10)
Rac Inhibition (10)
Integrin α Inhibition (71,72,73)
Integrin β Enhance Src
interaction
(73,74,
75)
c-fos Inhibition (71)
Actin
Cytoskeleton
Uncoupling from
adhesive proteins
(69)
E-Cadherin Inhibition (70)
γ-catenin Inhibition (70)
Vinculin Inhibition (70)
Fibronectin Protein level Up-
regulation
(70)
Snail Protein Level Up-
regulation
(70)
PTEN Inhibition (70,76,77)
Akt Activation (70,76,77)
PDGFR Activation (75)
Eph Activation (75)
EGFR Activation (78)
PTP1B Inhibition (78)
KCNN4 Activation (79)
Phosphoinositides Dephosphorylation (80)
miR 21,17,19a Induction (81)
miR 495, 551a Induction (82)
STAT5 Activation (43)
Histone
Deacetylase 4
Activation (43)
Mcl-1 Induction (43)